The Univeristy of Melbourne The Royal Melbourne Hopspital

A joint venture between The University of Melbourne and The Royal Melbourne Hospital

Our Work

Where we work

This map shows current Global Health activities undertaken by the Doherty Institute, including research collaborations, public health interventions, training, capacity building and consulting.

Global projects

Global Burden of Disease Study; WHO Advisory group on hepatitis

WHO Collaborating Centre for Viral Hepatitis
Project leader(s): Professor Benjamin Cowie
Collaborator(s): World Health Organisation

The WHO Collaborating Centre for Viral Hepatitis performs a broad range of activities supporting national and global control of viral hepatitis, including basic research, reference virology and diagnostics, surveillance strengthening and evaluation, treatment and prevention initiatives, situational analysis, and training and regional capacity building. In addition, the Centre is active in public health policy development and assists WHO in developing and reviewing technical guidelines and operational plans across the region.

In conjunction with the designation as a WHO Regional Reference Laboratory for Hepatitis B in 2010, the Centre assists the WHO and Western Pacific Regional Office (WPRO) with advice and support for approaches to the prevention and management of viral hepatitis, and provides technical support on laboratory diagnostics.

The Centre also enables the Victorian Infectious Diseases Reference Laboratory (VIDRL) and the Doherty Institute to extend the scope and geographic reach of their research, training and regional capacity building activities related to viral hepatitis.

Global transmission and vaccinology of Streptococcus pyogenes

Davies group
Project leader(s): Dr Mark Davies
Collaborator(s): University of Hong KongFudan University

Global immunisation strategy and policy.

Biggs group 
Project leader(s): Dr Christopher Morgan
Collaborator(s): World Health Organisation

Consultations and writing to develop the global immunisation strategy for the next ten years (2021 - 2030).

Vaccines Innovations Prioritisation Working Group

Biggs group 
Project leader(s): Dr Christopher Morgan
Collaborator(s): World Health OrganisationGaviPATHThe Bill and Melinda Gates Foundation

Dr Christopher Morgan is a member of the Vaccines Innovations Prioritisation Working Group, a multi-partner program of WHO, Gavi, PATH and the Bill and Melinda Gates Foundation. This is a global group to identify which new techniques to administer, store or track vaccines represents the best investment opportunity for global immunization partners.

Insights from mathematical modelling on the proposed WHO 2030 goals for scabies

McVernon group and the Victorian Infectious Diseases Reference Laboratory 
Project leader(s): Professor Jodie McVernon
Collaborator(s): World Health Organisation Neglected Tropical Diseases Program

We contributed insights from mathematical models of scabies transmission to a WHO informal consultation on measures to control or eliminate scabies as a public health problem. Key messages were published in Gates Open Research.

Transmission and emerging antibiotic resistance of Staphylococcus aureus

Tong group
Project leader(s): Associate Professor Steven Tong
Collaborator(s): Sanger Institute

Researching the transmission and emerging antibiotic resistance of S.aureus globally. Conducting clinical trials for S. aureus disease.

Protocol development for MERS coronavirus testing

Victorian Infectious Diseases Reference Laboratory 
Project leader(s): Dr Leon Caly
Collaborator(s): National Institute for Biolocical Standards and Controls, UK.

The Victorian Infectious Diseases Reference Laboratory contributed insights from mathematical models of scabies transmission to a World Health Organization informal consultation on measures to control or eliminate scabies as a public health problem. Key messages were published in Gates Open Research.

International Coalition to Eliminate HBV

Project leader(s): Professor Peter RevillCapucine Penicaud
Collaborator(s): 121 partners globally
Funding: ANRS, Hepatitis B Foundation, International HBV Meeting

The International Coalition to Eliminate HBV (ICE-HBV) aims to fast-track the discovery of a safe, effective, affordable and scalable cure to benefit all people living with chronic hepatitis B (CHB), including children and people living with HCV, HDV and HIV co-infection. ICE-HBV intends to contribute to the elimination of CHB as a global public health challenge. To achieve this, we provide an international research-driven forum, which is coordinating, promoting and establishing public-private collaborative partnerships to accelerate the discovery of a CHB cure.

WHO Collaborating Centre for Viral Hepatitis

Victorian Infectious Diseases Reference Laboratory 

The Centre performs a broad range of activities supporting national and global control of viral hepatitis, including basic research and reference virology, surveillance, treatment and prevention initiatives, and training and regional capacity building. In addition, the Centre is active in public health policy development and assists the WHO in implementing the Global Health Sector Strategy on Viral Hepatitis.

WHO Collaborating Centre for Reference and Research on Influenza

Victorian Infectious Diseases Reference Laboratory 

Together with the WHO Collaborating Centres in Atlanta, Beijing, London and Tokyo, the Centre is responsible for analysing influenza viruses currently circulating in the human population across the globe. This information is used by the WHO to make recommendations on appropriate viruses to be included in annual seasonal influenza vaccines for the northern and southern hemispheres. The Centre also undertakes research, training and regional capacity building activities related to influenza.